Publishing in face of the COVID-19 pandemic
Journal
International Journal of Antimicrobial Agents
Journal Volume
56
Journal Issue
1
Date Issued
2020
Author(s)
Abstract
Doctors around the world are desperately looking for guidance to enable them to better manage their COVID-19 patients. With no specific COVID-19 agents available a range of possible treatment options have been investigated including the use of anti-retroviral drugs, such as lopinavir/ritonavir, experimental anti-virals such as remdesivir, and antimicrobial drugs such as chloroquine or hydroxychloroquine with or without azithromycin. While some of these drugs are widely used for other indications, the risk/benefit analysis in COVID-19 patients has not thoroughly been evaluated.
SDGs
Other Subjects
azithromycin; hydroxychloroquine; content analysis; coronavirus disease 2019; Editorial; human; pandemic; peer review; priority journal; publication; publishing; social media; virus transmission; Betacoronavirus; Coronavirus infection; pandemic; virus pneumonia; Betacoronavirus; Coronavirus Infections; Humans; Pandemics; Pneumonia, Viral; Publishing
Type
editorial